Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4
Index Copernicus  – 168.52; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Innovations in Therapeutic Interventions

Advances in Clinical and Experimental Medicine


Adv Clin Exp Med


Call for submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on


Innovations in Therapeutic Interventions: Advancing Clinical and Experimental Medicine


Handling Editors

Dr. Masaru Tanaka (ELKH-SZTE Neuroscience Research Group, Eötvös Loránd Research Network, University of Szeged (ELKH-SZTE), Hungary)

Dr. Simone Battaglia (Center for Studies and Research in Cognitive Neuroscience, Department of Psychology, University of Bologna, Italy

Dr. Francesco Di Gregorio (AUSL Bologna; Department of Psychology, University of Bologna, Italy)

Prof. Izabella Uchmanowicz (Wroclaw Medical University, Poland)

Prof. Donata Kurpas (Wroclaw Medical University, Poland)


Dear Researchers and Academics,


Advances in Clinical and Experimental Medicine (Adv Clin Exp Med; IF 2.1, Scopus CiteScore 3.4) cordially invites you to contribute your valuable research to our esteemed journal. We are dedicated to promoting groundbreaking advancements in clinical and experimental medicine, focusing on emerging therapeutic strategies. We aim to enhance our impact factor and facilitate collaborations that drive progress in medicine.

We welcome reviews as well as original research articles and research letters in various clinical and experimental medicine areas. We encourage submissions on the following topics:


Precision Medicine and Personalized Therapies: Explore novel approaches in tailoring medical treatments based on an individual's genetic makeup, environmental factors, and disease characteristics. Highlight the potential of precision medicine in improving patient outcomes and overcoming treatment challenges. This topic includes but is not limited to:

  • Immunotherapy and Immunomodulation: Investigate the role of immunotherapy and immunomodulation in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Focus on cutting-edge techniques, therapeutic targets and potential synergies with other treatment modalities;
  • Gene and Cell Therapies: Present innovative research on gene and cell-based therapies, such as stem cell transplantation, gene editing and regenerative medicine. Explore their applications across different diseases and discuss their clinical implications and prospects.

Artificial Intelligence and Big Data Analytics in Medicine: Examine the integration of artificial intelligence (AI) and big data analytics in medical research, diagnostics, treatment optimization, and patient care. Highlight the potential of AI algorithms, machine learning and data-driven approaches in revolutionizing healthcare practices.

Digital Health Technologies and Wearables: Discuss the advancements in digital health technologies (including telemedicine), wearable devices and remote monitoring systems. Explore their impact on healthcare delivery, patient engagement, disease management, and prevention strategies.


All papers should focus on:

Translational Research and Bench-to-Bedside Innovations: Showcase translational research efforts that bridge the gap between laboratory discoveries and clinical applications. Present successful examples of bench-to-bedside innovations that have improved patient care and outcomes.



therapeutic interventions; personalized therapies; immunotherapy; immunomodulation; gene and cell therapies; artificial intelligence; Big Data analytics; digital health technologies


By submitting your research to Adv Clin Exp Med, you will become an integral part of a dynamic and vibrant community of dedicated researchers committed to advancing the fields of clinical and experimental medicine. By undergoing our rigorous peer-review process, you can be assured that only high-quality and impactful studies are published, enhancing your professional reputation and contributing to advancing medical knowledge.

We look forward to receiving your submissions and collaborating to make a lasting impact on the field of clinical and experimental medicine.


Submission process

As a first step, we ask for submissions of an Expression of Interest with an Abstract of original papers outlining the themes above to Adv Clin Exp Med Managing Editor Marek Misiak:

The Editor-in-Chief will review all submissions and select those invited to submit a full paper. The submission process will follow the regular Adv Clin Exp Med online process. All manuscripts will be sent to at least two independent reviewers.


Dates and fees

Submission of Expression of Interest until January 31, 2024, to the ACEM Managing Editor:;

Invitation to submit the full paper by March 1, 2024;

Submission of full paper by June 30, 2024.


If accepted, Authors will be required to pay a fee to cover publication costs ( For selected Authors (outstanding experts), reducing or even cancelling the publication fee is possible.

We look forward to a wide variety and genuinely global collection of papers and experiences to push worldwide science to the next level!